Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Gastrointestinal Stromal Tumors × Esomeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 5 Gastritis 4 Peptic Ulcer 3 Dyspepsia 3 Barrett Esophagus 3 Stomach Ulcer 2 Colorectal Neoplasms 2 Peptic Ulcer Hemorrhage 1 Gastrointestinal Stromal Tumors 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Dysbiosis 1 Colonic Neoplasms 1

Interventions

Sunitinib 2 Imatinib Mesylate 2 regorafenib 1 nilotinib 1 avapritinib 1 Oxaliplatin 1 Midazolam 1 Lead 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Caffeine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02800330 2018-08-02

REGORA

Erasmus Medical Center

Phase 4 Completed

GastrointestinalSarcoma

Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡